prof. Filip Van den Bosch

Journal Article
A1
open access

EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis

Helena Marzo-Ortega, Stephanie R. Harrison, George E. Fragoulis, Xabier Michelena, Cristina Macia-Villa, Sibel Z. Aydin, Andra Balanescu, Heidi Bertheussen, Christine Bundy, Maria Sole Chimenti, et al.

(2026) ANNALS OF THE RHEUMATIC DISEASES. 85(1). p.61-74

Add to list

Work participation and work disability in Belgian patients with systemic sclerosis

Ine Desimpele (UGent) , Ann-Sophie De Craemer (UGent) , Saskia Decuman, Annick Viaene (UGent) , Piet Mortele, Lauren Delmez (UGent) , Philippe Carron (UGent) , Dirk Elewaut (UGent) , Filip Van den Bosch (UGent) and Vanessa Smith (UGent)

(2026) RHEUMATOLOGY. 65(1).

Add to list

Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis : a GRAPPA initiative

Fabian Proft, Andre L. Ribeiro, Shikha Singla, Vinod Chandran, Wilson Liao, Christine Lindsay, Enrique R. Soriano, Tina Bhutani, Atul Deodhar, Kurt De Vlam, et al.

(2026) NATURE REVIEWS RHEUMATOLOGY. 22(2). p.132-144

Add to list

Journal Article
A1
open access

ASAS recommendations on reporting axial spondyloarthritis clinical trials

Floris A. Van Gaalen, Victoria Navarro-Compa, Xenofon Baraliakos, Filip Van den Bosch (UGent) , Lianne S. Gensler, Ihsane Hmamouchi, Robert Landewe, Pedro M. Machado, Helena Marzo-Ortega, Valeria Rios Rodriguez, et al.

(2025) ANNALS OF THE RHEUMATIC DISEASES. 84(11). p.1770-1778

Add to list

Journal Article
A1
open access

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis : a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

Laura C. Coates, Ricardo Blanco, Frank Behrens, Alexis Ogdie, Filip Van den Bosch (UGent) , Roberto Ranza, Yael Klionsky, Ahmed M. Soliman, Michael Chen, Derek Coombs, et al.

(2025) RMD OPEN. 11(3).

Add to list

Journal Article
A1
open access

Efficacy and safety of risankizumab for active psoriatic arthritis : 196-week results from the KEEPsAKE 1 and KEEPsAKE 2 randomized clinical trials

Andrew Ostor, Filip Van den Bosch (UGent) , Kim Papp, Mauro Keiserman, Ricardo Blanco, Angela Crowley, Douglas White, Ana Biljan, Tshepiso Madihlaba, Kyle Carter, et al.

(2025) RHEUMATOLOGY AND THERAPY. 12(6). p.1103-1123

Add to list

Journal Article
A1
open access

Measurement properties of disease activity instruments in peripheral spondyloarthritis : a post-hoc analysis of the CRESPA trial

Clementina Lopez-Medina, Dafne Capelusnik, Casper Webers, Filip Van den Bosch (UGent) , Annelies Boonen, Philippe Carron (UGent) , Anna Molto and Sofia Ramiro

(2025) RMD OPEN. 11(3).

Add to list

Journal Article
A1
open access

The assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis

Denis Poddubnyy, Victoria Navarro-Compan, Murat Torgutalp, Suzanne Arends, Sibel Zehra Aydin, Simone Battista, Filip Van den Bosch (UGent) , Christine Bundy, Alberto Cauli, Jo Davies, et al.

(2025) ANNALS OF THE RHEUMATIC DISEASES. 84(4). p.538-546

Add to list

Journal Article
A1
open access

Long-term evolution of postpartum sacroiliac bone marrow oedema : a 5-year longitudinal follow-up study

Gaëlle Varkas (UGent) , Liesbet De Meester, Manouk de Hooge (UGent) , Ann-Sophie De Craemer (UGent) , Nele Herregods (UGent) , Lennart Jans (UGent) , Philippe Carron (UGent) , Dirk Elewaut (UGent) and Filip Van den Bosch (UGent)

(2025) RMD OPEN. 11(2).

Add to list

Journal Article
A1
open access

Efficacy of golimumab in early axial spondyloarthritis in relation to gut inflammation (GO‐GUT) : an early remission induction study

Zuzanna Łukasik (UGent) , Ann-Sophie De Craemer (UGent) , Thomas Renson (UGent) , Liselotte Deroo (UGent) , Gaëlle Varkas (UGent) , Manouk de Hooge (UGent) , Jan Lenaerts, Anne Hoorens (UGent) , Claude Cuvelier (UGent) , Triana Lobatón Ortega (UGent) , et al.

(2025) ARTHRITIS & RHEUMATOLOGY. 78(1). p.119-130

Academic Bibliography

prof. Filip Van den Bosch

EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis

Work participation and work disability in Belgian patients with systemic sclerosis

Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis : a GRAPPA initiative

ASAS recommendations on reporting axial spondyloarthritis clinical trials

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis : a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

Efficacy and safety of risankizumab for active psoriatic arthritis : 196-week results from the KEEPsAKE 1 and KEEPsAKE 2 randomized clinical trials

Measurement properties of disease activity instruments in peripheral spondyloarthritis : a post-hoc analysis of the CRESPA trial

The assessment of SpondyloArthritis International Society (ASAS) consensus-based expert definition of difficult-to-manage, including treatment-refractory, axial spondyloarthritis

Long-term evolution of postpartum sacroiliac bone marrow oedema : a 5-year longitudinal follow-up study

Efficacy of golimumab in early axial spondyloarthritis in relation to gut inflammation (GO‐GUT) : an early remission induction study

Contents

Support

Contact